Reuters logo
BRIEF-Evoke pharma completes dosing for Gimoti™comparative exposure Pharmacokinetic study
2017年9月12日 / 下午2点18分 / 2 个月前

BRIEF-Evoke pharma completes dosing for Gimoti™comparative exposure Pharmacokinetic study

Sept 12 (Reuters) - Evoke Pharma Inc

* Evoke pharma completes dosing for Gimoti™ comparative exposure Pharmacokinetic study

* Evoke pharma - expects to announce data from Pharmacokinetic trial in Q4 of 2017, followed by 505(b)(2) NDA submission by end of 2017 or early 2018​‍​‍​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below